Jean-Marc DuFour

Title: The Innovations of Jean-Marc DuFour

Introduction

Jean-Marc DuFour is a notable inventor based in Pierrefonds, Canada. He has made significant contributions to the field of chemistry, particularly in the development of chelating compounds. With a total of 4 patents to his name, DuFour's work has implications in both medical and industrial applications.

Latest Patents

Among his latest patents, DuFour has developed bifunctional chelating compounds containing hydroxamic acid residues. These innovative chelators are designed to bind metal ions that can be detected through their paramagnetic or radioactive properties. Additionally, he has created novel N.sub.3 S.sub.2 chelating ligands that can be radiolabeled with elements such as Technetium (Tc) or Rhenium (Re). These ligands are particularly useful for radiolabeling peptides, including somatostatin derivatives, which are valuable for the selective detection and treatment of tumors with somatostatin receptors.

Career Highlights

DuFour has had a distinguished career, working with prominent companies such as Merck Frosst Canada, Inc. and Merck & Co., Inc. His experience in these organizations has allowed him to refine his expertise in the development of innovative chemical compounds.

Collaborations

Throughout his career, DuFour has collaborated with esteemed colleagues, including Richard J. Flanagan and Keith T. Hogan. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Jean-Marc DuFour's contributions to the field of chemistry through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new technologies in medical and industrial applications.